Tom P Freeman
Tom P Freeman
Reader, Addiction and Mental Health Group, Department of Psychology, University of Bath
Verified email at
Cited by
Cited by
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
M Di Forti, D Quattrone, TP Freeman, G Tripoli, C Gayer-Anderson, ...
The Lancet Psychiatry 6 (5), 427-436, 2019
Keep off the grass? Cannabis, cognition and addiction
HV Curran, TP Freeman, C Mokrysz, DA Lewis, CJA Morgan, LH Parsons
Nature Reviews Neuroscience 17 (5), 293-306, 2016
New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
S Chandra, MM Radwan, CG Majumdar, JC Church, TP Freeman, ...
European archives of psychiatry and clinical neuroscience 269, 5-15, 2019
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
CJA Morgan, G Schafer, TP Freeman, HV Curran
The British Journal of Psychiatry 197 (4), 285-290, 2010
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
TP Freeman, AR Winstock
Psychological medicine 45 (15), 3181-3189, 2015
Cannabidiol attenuates the appetitive effects of Δ9-tetrahydrocannabinol in humans smoking their chosen cannabis
CJA Morgan, TP Freeman, GL Schafer, HV Curran
Neuropsychopharmacology 35 (9), 1879-1885, 2010
Medicinal use of cannabis based products and cannabinoids
TP Freeman, C Hindocha, SF Green, MAP Bloomfield
Bmj 365, 2019
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
CJA Morgan, C Gardener, G Schafer, S Swan, C Demarchi, TP Freeman, ...
Psychological medicine 42 (2), 391-400, 2012
The neuropsychopharmacology of cannabis: A review of human imaging studies
MAP Bloomfield, C Hindocha, SF Green, MB Wall, R Lees, K Petrilli, ...
Pharmacology & therapeutics 195, 132-161, 2019
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
E Chesney, D Oliver, A Green, S Sovi, J Wilson, A Englund, TP Freeman, ...
Neuropsychopharmacology 45 (11), 1799-1806, 2020
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
AM Freeman, K Petrilli, R Lees, C Hindocha, C Mokrysz, HV Curran, ...
Neuroscience & Biobehavioral Reviews 107, 696-712, 2019
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
TP Freeman, S Craft, J Wilson, S Stylianou, M ElSohly, M Di Forti, ...
Addiction 116 (5), 1000-1010, 2021
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis …
C Hindocha, TP Freeman, G Schafer, C Gardener, RK Das, CJA Morgan, ...
European Neuropsychopharmacology 25 (3), 325-334, 2015
‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration
TP Freeman, V Lorenzetti
Addiction 115 (7), 1207-1216, 2020
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
TP Freeman, C Hindocha, G Baio, NDC Shaban, EM Thomas, D Astbury, ...
The Lancet Psychiatry 7 (10), 865-874, 2020
Can we make cannabis safer?
A Englund, TP Freeman, RM Murray, P McGuire
The Lancet Psychiatry 4 (8), 643-648, 2017
No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit
C Hindocha, TP Freeman, JA Ferris, MT Lynskey, AR Winstock
Frontiers in psychiatry 7, 104, 2016
Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
TP Freeman, CJA Morgan, C Hindocha, G Schafer, RK Das, HV Curran
Addiction 109 (10), 1686-1694, 2014
Association of high-potency cannabis use with mental health and substance use in adolescence
LA Hines, TP Freeman, SH Gage, S Zammit, M Hickman, M Cannon, ...
JAMA psychiatry 77 (10), 1044-1051, 2020
Increasing potency and price of cannabis in Europe, 2006–16
TP Freeman, T Groshkova, A Cunningham, R Sedefov, P Griffiths, ...
Addiction 114 (6), 1015-1023, 2019
The system can't perform the operation now. Try again later.
Articles 1–20